{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T06:47:00Z","timestamp":1775890020836,"version":"3.50.1"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,9]],"date-time":"2021-03-09T00:00:00Z","timestamp":1615248000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002383","name":"King Saud University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002383","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Saudi Pharmaceutical Journal"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.jsps.2021.03.003","type":"journal-article","created":{"date-parts":[[2021,3,24]],"date-time":"2021-03-24T16:49:44Z","timestamp":1616604584000},"page":"315-323","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Efficacy of clotrimazole for the management of oral candidiasis: A meta-analysis of randomized clinical trials"],"prefix":"10.1007","volume":"29","author":[{"given":"Thamer A.","family":"Almangour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith S.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Alessa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalid","family":"Eljaaly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fadilah","family":"Sfouq Aleanizy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aynaa","family":"Alsharidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fahad M.","family":"Al Majid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naif H.","family":"Alotaibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah A","family":"Alzeer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faris S.","family":"Alnezary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdullah A.","family":"Alhifany","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"issue":"2","key":"10.1016\/j.jsps.2021.03.003_b0005","doi-asserted-by":"crossref","first-page":"83","DOI":"10.2165\/00002018-199818020-00001","article-title":"Systemic antifungal agents. Drug interactions of clinical significance","volume":"18","author":"Albengres","year":"1998","journal-title":"Drug Saf."},{"issue":"3","key":"10.1016\/j.jsps.2021.03.003_b0010","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/j.1439-0507.2005.01124.x","article-title":"Candidal overgrowth in diabetic patients: potential predisposing factors","volume":"48","author":"Belazi","year":"2005","journal-title":"Mycoses"},{"issue":"8","key":"10.1016\/j.jsps.2021.03.003_b0015","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/j.1365-2842.2007.01754.x","article-title":"Relationship between Candida and nocturnal denture wear: quantitative study","volume":"34","author":"Compagnoni","year":"2007","journal-title":"J. Oral Rehabil."},{"issue":"4","key":"10.1016\/j.jsps.2021.03.003_b0020","first-page":"627","article-title":"Comparitive evaluation on nystatin pastille and clotrimazole troche for the treatment of candidal stomatitis in immunocompromised patients","volume":"47","author":"Conrad","year":"1990","journal-title":"Curr. Therap. Res. \u2013 Clin. Exp."},{"issue":"3","key":"10.1016\/j.jsps.2021.03.003_b0025","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/jam.12554","article-title":"Clotrimazole as a pharmaceutical: past, present and future","volume":"117","author":"Crowley","year":"2014","journal-title":"J. Appl. Microbiol."},{"issue":"2","key":"10.1016\/j.jsps.2021.03.003_b0030","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jdent.2013.11.021","article-title":"Linking evidence to treatment for denture stomatitis: a meta-analysis of randomized controlled trials","volume":"42","author":"Emami","year":"2014","journal-title":"J. Dent."},{"issue":"Suppl 1","key":"10.1016\/j.jsps.2021.03.003_b0035","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1834-7819.2010.01198.x","article-title":"Oral fungal infections: an update for the general practitioner","volume":"55","author":"Farah","year":"2010","journal-title":"Aust. Dent. J."},{"issue":"6","key":"10.1016\/j.jsps.2021.03.003_b0040","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1111\/j.1365-2842.2007.01709.x","article-title":"Denture-related stomatitis: identification of aetiological and predisposing factors \u2013 a large cohort","volume":"34","author":"Figueiral","year":"2007","journal-title":"J. Oral Rehabil."},{"issue":"2","key":"10.1016\/j.jsps.2021.03.003_b0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1042\/bj2660475","article-title":"Interaction of azole antifungal antibiotics with cytochrome P-450-dependent 14 alpha-sterol demethylase purified from Candida albicans","volume":"266","author":"Hitchcock","year":"1990","journal-title":"Biochem. J."},{"issue":"22","key":"10.1016\/j.jsps.2021.03.003_b0050","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJM197811302992201","article-title":"Treatment of chronic oral candidiasis with clotrimazole troches. A controlled clinical trial","volume":"299","author":"Kirkpatrick","year":"1978","journal-title":"N. Engl. J. Med."},{"issue":"11","key":"10.1016\/j.jsps.2021.03.003_b0055","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1128\/AAC.34.11.2267","article-title":"Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus","volume":"34","author":"Koletar","year":"1990","journal-title":"Antimicrob. Agents Chemother."},{"issue":"6 I","key":"10.1016\/j.jsps.2021.03.003_b0060","first-page":"774","article-title":"Comparison of clotrimazole troche and nystatin vaginal tablet in the treatment of oropharyngeal candidiasis","volume":"27","author":"Lawson","year":"1980","journal-title":"Curr. Therap. Res. \u2013 Clin. Exp."},{"issue":"11","key":"10.1016\/j.jsps.2021.03.003_b0065","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1046\/j.1365-4362.2000.00087.x","article-title":"Clinical trial: clotrimazole troche vs. itraconazole oral solution in the treatment of oral candidosis in AIDS patients","volume":"39","author":"Linpiyawan","year":"2000","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jsps.2021.03.003_b0070","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.2147\/DDDT.S100795","article-title":"Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis","volume":"10","author":"Lyu","year":"2016","journal-title":"Drug Des Devel Ther"},{"issue":"4","key":"10.1016\/j.jsps.2021.03.003_b0075","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.clindermatol.2016.02.022","article-title":"Oral candidiasis","volume":"34","author":"Millsop","year":"2016","journal-title":"Clin. Dermatol."},{"issue":"2","key":"10.1016\/j.jsps.2021.03.003_b0080","first-page":"277","article-title":"Clotrimazole troches: a new therapeutic approach to oral candidiasis","volume":"17","author":"Montes","year":"1976","journal-title":"Cutis"},{"issue":"3","key":"10.1016\/j.jsps.2021.03.003_b0085","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S0149-2918(97)80131-2","article-title":"Itraconazole oral solution versus clotrimazole troches for the treatment of oropharyngeal candidiasis in immunocompromised patients","volume":"19","author":"Murray","year":"1997","journal-title":"Clin. Ther."},{"issue":"3","key":"10.1016\/j.jsps.2021.03.003_b0090","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MMBR.67.3.400-428.2003","article-title":"Candida albicans secreted aspartyl proteinases in virulence and pathogenesis","volume":"67","author":"Naglik","year":"2003","journal-title":"Microbiol. Mol. Biol. Rev."},{"issue":"3","key":"10.1016\/j.jsps.2021.03.003_b0095","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1601-0825.1996.tb00223.x","article-title":"Aetiological factors for oral manifestations of HIV","volume":"2","author":"Palmer","year":"1996","journal-title":"Oral Dis."},{"issue":"4","key":"10.1016\/j.jsps.2021.03.003_b0100","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the infectious diseases society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jsps.2021.03.003_b0105","first-page":"262471","article-title":"The changing epidemiology of oropharyngeal candidiasis in patients with HIV\/AIDS in the era of antiretroviral therapy","volume":"2012","author":"Patel","year":"2012","journal-title":"AIDS Res. Treat."},{"issue":"11","key":"10.1016\/j.jsps.2021.03.003_b0110","first-page":"Cd003940","article-title":"Interventions for the prevention and management of oropharyngeal candidiasis associated with HIV infection in adults and children","author":"Pienaar","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"12","key":"10.1016\/j.jsps.2021.03.003_b0115","first-page":"1311","article-title":"Therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, prospective multicenter study of oral fluconazole versus clotrimazole troches. The Multicenter Study Group","volume":"6","author":"Pons","year":"1993","journal-title":"J. Acquir. Immune Defic. Syndr."},{"issue":"1","key":"10.1016\/j.jsps.2021.03.003_b0120","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1754-4505.1992.tb00402.x","article-title":"A comparison between fluconazole tablets and clotrimazole troches for the treatment of thrush in HIV infection","volume":"12","author":"Redding","year":"1992","journal-title":"Spec. Care Dentist."},{"issue":"2","key":"10.1016\/j.jsps.2021.03.003_b0125","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1258\/0049475054037084","article-title":"Efficacy of garlic paste in oral candidiasis","volume":"35","author":"Sabitha","year":"2005","journal-title":"Trop. Doct."},{"issue":"4","key":"10.1016\/j.jsps.2021.03.003_b0130","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0002-9343(94)90300-X","article-title":"Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance","volume":"97","author":"Sangeorzan","year":"1994","journal-title":"Am. J. Med."},{"issue":"4","key":"10.1016\/j.jsps.2021.03.003_b0135","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1034\/j.1601-0825.2003.03967.x","article-title":"Drug effects on salivary glands: dry mouth","volume":"9","author":"Scully","year":"2003","journal-title":"Oral Dis."},{"key":"10.1016\/j.jsps.2021.03.003_b0140","doi-asserted-by":"crossref","first-page":"g7647","DOI":"10.1136\/bmj.g7647","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation","volume":"350","author":"Shamseer","year":"2015","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.jsps.2021.03.003_b0145","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0002-9343(84)90755-1","article-title":"Clotrimazole treatment of oral candidiasis in patients with neoplastic disease","volume":"76","author":"Shechtman","year":"1984","journal-title":"Am. J. Med."},{"issue":"7","key":"10.1016\/j.jsps.2021.03.003_b0150","first-page":"521","article-title":"Oral candidosis","volume":"33","author":"Sherman","year":"2002","journal-title":"Quintessence Int."},{"issue":"1","key":"10.1016\/j.jsps.2021.03.003_b0155","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/S1079-2104(03)00160-4","article-title":"The relationship between oral Candida carriage and the secretor status of blood group antigens in saliva","volume":"96","author":"Shin","year":"2003","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"4","key":"10.1016\/j.jsps.2021.03.003_b0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1834-7819.2009.01160.x","article-title":"Comparison of efficacy of fluconazole mouthrinse and clotrimazole mouthpaint in the treatment of oral candidiasis","volume":"54","author":"Sholapurkar","year":"2009","journal-title":"Aust. Dent. J."},{"issue":"2","key":"10.1016\/j.jsps.2021.03.003_b0165","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/j.1601-0825.2006.01357.x","article-title":"Antimicrobials as a contributory factor in oral candidosis\u2013a brief overview","volume":"14","author":"Soysa","year":"2008","journal-title":"Oral Dis."},{"issue":"12","key":"10.1016\/j.jsps.2021.03.003_b0170","first-page":"654","article-title":"Randomized controlled trial of clotrimazole troche and ketoconazole for oropharyngeal candidiasis","volume":"71","author":"Thamlikitkul","year":"1988","journal-title":"J. Med. Assoc. Thai."},{"issue":"4","key":"10.1016\/j.jsps.2021.03.003_b0175","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.tripleo.2009.11.026","article-title":"Oropharyngeal candidiasis in the era of antiretroviral therapy","volume":"109","author":"Thompson","year":"2010","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"4","key":"10.1016\/j.jsps.2021.03.003_b0180","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1310\/hct1104-186","article-title":"Randomized, comparative, double-blind, double-dummy, multicenter trial of miconazole buccal tablet and clotrimazole troches for the treatment of oropharyngeal candidiasis: study of miconazole lauriad<sup>\u00ae<\/ sup> efficacy and safety (SMiLES)","volume":"11","author":"Vazquez","year":"2010","journal-title":"HIV Clin Trials"},{"key":"10.1016\/j.jsps.2021.03.003_b0185","unstructured":". WHO Guidelines Approved by the Guidelines Review Committee, 2014. In: Guidelines on the Treatment of Skin and Oral HIV-Associated Conditions in Children and Adults. Geneva: World Health Organization Copyright (c) World Health Organization."},{"issue":"3","key":"10.1016\/j.jsps.2021.03.003_b0190","first-page":"Cd003807","article-title":"Interventions for preventing oral candidiasis for patients with cancer receiving treatment","author":"Worthington","year":"2002","journal-title":"Cochrane Database Syst. Rev."},{"issue":"7","key":"10.1016\/j.jsps.2021.03.003_b0195","first-page":"Cd001972","article-title":"Interventions for treating oral candidiasis for patients with cancer receiving treatment","author":"Worthington","year":"2010","journal-title":"Cochrane Database Syst. Rev."},{"issue":"6","key":"10.1016\/j.jsps.2021.03.003_b0200","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/archinte.1979.03630430036012","article-title":"Oropharyngeal candidiasis treated with a troche form of clotrimazole","volume":"139","author":"Yap","year":"1979","journal-title":"Arch. Intern. Med."},{"issue":"3","key":"10.1016\/j.jsps.2021.03.003_b0205","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/odi.12380","article-title":"Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis","volume":"22","author":"Zhang","year":"2016","journal-title":"Oral Dis."}],"container-title":["Saudi Pharmaceutical Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1319016421000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,6]],"date-time":"2025-01-06T17:25:35Z","timestamp":1736184335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1319016421000426"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":41,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1319016421000426"],"URL":"https:\/\/doi.org\/10.1016\/j.jsps.2021.03.003","relation":{},"ISSN":["1319-0164"],"issn-type":[{"value":"1319-0164","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of clotrimazole for the management of oral candidiasis: A meta-analysis of randomized clinical trials","name":"articletitle","label":"Article Title"},{"value":"Saudi Pharmaceutical Journal","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jsps.2021.03.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V. on behalf of King Saud University.","name":"copyright","label":"Copyright"}]}}